Pharmathen S.A.

Overview

Pharmathen S.A. is a private pharmaceutical company based in Greece, specializing in the development and manufacturing of generic and innovative pharmaceuticals. With a strong focus on research and development, the company aims to deliver high-quality medications across various therapeutic areas.

Therapeutic areas

API / Drug Master Files

Pharmathen S.A. holds 5 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• BRINZOLAMIDEActive2019-10-07
• APREPITANTActive2017-12-06
• VALGANCICLOVIR HYDROCHLORIDEActive2017-05-12
• VORICONAZOLEActive2017-05-10
• PALIPERIDONEActive2016-12-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Pharmathen S.A. in our records. PharmaTek screens the full directory against live FDA enforcement data.